Related Drugs
Urokinase for injection
Indication: This product is mainly used for thrombolytic therapy of thromboembolic diseases. Including acute extensive pulmonary embolism, coronary artery embolism and myocardial infarction within 6 to 12 hours of chest pain, acute cerebral vascular embolism with symptoms shorter than 3 to 6 hours, retinal artery embolism and other patients with severe iliac-femoral vein thrombosis with peripheral arterial embolism symptoms. It is also used to prevent thrombosis after artificial heart valve surgery, maintain patency of vascular cannulation and chest and pericardial drainage tubes, etc. The efficacy of thrombolysis requires subsequent heparin anticoagulation to maintain.
Manufacturer:
Livzon (GROUP) Pharmaceutical FACTORY
Urokinase for injection
Indication: This product is mainly used for thrombolytic therapy of thromboembolic diseases. Including acute extensive pulmonary embolism, coronary artery embolism and myocardial infarction within 6-12 hours of chest pain, acute cerebral vascular embolism with symptoms shorter than 3-6 hours, retinal artery embolism and other patients with severe iliac-femoral vein thrombosis with peripheral arterial embolism symptoms. It is also used to prevent thrombosis after artificial heart valve surgery, maintain patency of vascular cannulation and chest and pericardial drainage tubes, etc. The efficacy of thrombolysis requires subsequent heparin anticoagulation to maintain.
Manufacturer:
Guangdong Jianxin Pharmaceutical Co., Ltd.
Urokinase for injection
Indication: The product is mainly used for thrombolytic therapy of thromboembolic diseases, including acute extensive pulmonary embolism, coronary artery embolism and myocardial infarction within 6-12 hours of chest pain, acute cerebral vascular embolism with symptoms shorter than 3-6 hours, retinal artery embolism and other patients with severe iliac-femoral vein thrombosis with peripheral arterial embolism symptoms. It is also used to prevent thrombosis after artificial heart valve surgery, maintain patency of vascular cannulation and chest and pericardial drainage tubes, etc. The efficacy of thrombolysis requires subsequent heparin anticoagulation to maintain.
Manufacturer:
Ma'anshan Fengyuan Pharmaceutical Co., Ltd.
Low molecular weight heparin calcium
Indication: It is clinically used to prevent postoperative thromboembolism, deep vein thrombosis, pulmonary embolism, anticoagulant for extracorporeal circulation during hemodialysis, peripheral vascular disease, etc. A few data reports also show that it can be used for replacement therapy of allergies or thrombocytopenia caused by heparin. There are also reports of its use in special treatment of some embolic diseases.
Manufacturer:
Zhaoke Pharmaceutical (Hefei) Co., Ltd.
Low molecular weight heparin calcium
Indication: It is clinically used to prevent postoperative thromboembolism, deep vein thrombosis, pulmonary embolism, anticoagulant for extracorporeal circulation during hemodialysis, peripheral vascular disease, etc. A few data reports also show that it can be used for replacement therapy of allergies or thrombocytopenia caused by heparin. There are also reports of its use in special treatment of some embolic diseases.
Manufacturer:
Changshan Biochem PHARM(Jiangsu) Co., Ltd.
Low molecular weight heparin calcium
Indication: It is clinically used to prevent postoperative thromboembolism, deep vein thrombosis, pulmonary embolism, anticoagulant for extracorporeal circulation during hemodialysis, peripheral vascular disease, etc. A few data reports also show that it can be used for replacement therapy of allergies or thrombocytopenia caused by heparin. There are also reports of its use in special treatment of some embolic diseases.
Manufacturer:
Hainan General Alliance Pharmaceutical Co., Ltd.
Low Molecular Weight Heparin Calcium Injection
Indication: This product is mainly used to prevent blood clot formation during hemodialysis and can also be used to treat deep vein thrombosis.
Manufacturer:
Techpool BIO-PHARMA Co., Ltd.